BAMS
PFE icon

Bellevue Asset Management (Switzerland)’s Pfizer PFE Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$3.55M Buy
115,940
+26,350
+29% +$829K 0.54% 60
2015
Q3 		$2.67M Sell
89,590
-15,810
-15% -$507K 0.44% 71
2015
Q2 		$3.35M Sell
105,400
-84,320
-44% -$2.75M 0.47% 68
2015
Q1 		$6.26M Buy
+189,720
New +$6.03M 0.87% 44

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s PFE Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) increased its Pfizer (PFE) stake by 29% in Q4 2015, buying an estimated $829K and bringing the position to 115,940 shares worth $3.55M. The position accounts for 0.54% of the portfolio, ranked #60.

Bellevue Asset Management (Switzerland) first reported a position in PFE in Q1 2015 and has held it in 4 quarters since. The position peaked at $6.26M in Q1 2015. 1,970 funds tracked by Wall St. Rank hold PFE as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 115,940 shares of Pfizer worth $3.55M as of Q4 2015.
  • Bellevue Asset Management (Switzerland) bought 26,350 Pfizer shares in Q4 2015, an estimated $829K.
  • Pfizer made up 0.54% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #60 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in Pfizer in Q1 2015 and has held it in 4 quarters since.
  • Bellevue Asset Management (Switzerland)'s Pfizer position peaked at $6.26M in Q1 2015.
  • 1,970 funds tracked by Wall St. Rank held Pfizer as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.